Latest immunotherapy News

Genetic signature may predict lung cancer response to immunotherapy
Future Of Cancer Research With Professor Alex Swarbrick
MinterEllison advises Aravax on US$68 million raising for peanut allergy therapy
Funding turbocharges search for children’s brain cancer cure
Trial finds new bladder cancer treatment safe
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
Why Warren and Donna are Charging this March
Trial increases survival rates for mesothelioma patients
Capping off a year of generosity
Healthy investment in better patient outcomes
Improving survival rates for deadly lung diseases
King Charles is having cancer treatment. What can he, and others with cancer, expect?
Novel treatment for brain cancer in children
Immune networks in tumors prime responses to a personalized immunotherapy
New drug halts growth of aggressive breast cancer
Sowing seeds for better cancer outcomes
Improving cancer outcomes by helping regional patients join clinical trials
Arovella licences novel CARiNKT cell armouring technology
Pioneering melanoma researchers named 2024 Australian of the Year
Immunologist Lydia Lynch appointed member of Ludwig Princeton
Congratulations to NSW professor duo with top 2024 Australians of the Year honour
How a timekeeping gene affects tumor growth depends entirely on context
Investing in ground breaking peanut allergy therapy
Made In Victoria: Groundbreaking Peanut Allergy Therapy
From melanoma survivor to skin cancer advocate – Nicole’s story
Analysis of brain tumor blood vessels yields a candidate therapy-and a platform to find more
Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling
Combo treatment improves lung cancer outcomes
Young teacher shares his cancer story to educate students about sun safety
New therapy will revolutionise treatment of urothelial and bladder cancers
Works underway on Royal Hobart Hospital Pharmacy Redevelopment Project
Bright ideas attract major funding
New treatment for deadly uterine cancer
DFG Funding for Immunology Research in Würzburg
Monica’s message about skin cancer: It doesn’t discriminate, I wish more people would Slip, Slop, Slap
Cheaper medicines for breast cancer, small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and Crohn’s disease
Dr Ben Wylie research to develop kinder and less toxic treatments for cancer
Nutrient in beef and dairy products boosts immune response to cancer
Weill Cornell Medicine to open medical research center
New therapy target to shut down multiple myeloma’s ability to survive and thrive
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
Drug resistance may make common infections like thrush untreatable
$50 million boost to research for health problems
Unlocking power of immune system to kill prostate cancer
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
New culprit in amyloid beta buildup, neurodegeneration
Leukaemia Foundation and HSANZ funding next generation of clinicians and researchers to save more Australian lives
Preventing Exhaustion of T Cells